The effect of injection of Mitomycin c and Bevacizumab on intraocular pressure after Ahmed Glaucoma Valve (AGV) implantation surgery
Not Applicable
- Conditions
- eovascular glaucoma.Unspecified open-angle glaucoma, stage unspecifiedH40.10X0
- Registration Number
- IRCT20211207053323N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patient with uncontroll glaucoma and indicated for shunt
Exclusion Criteria
Age below 18 years
Neovascular glaucoma secondary to tumor or uveitis
Follow up less than 6 months
Previous shunt devices
Simultaneous intravitreal injection of bevacizumab (IVB)
Non-diabetic people with a history of failed trabeculectomy surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure reduction percentage after surgery. Timepoint: One week, four weeks, six weeks, eight weeks, three months and 6 months are followed. Method of measurement: Applanation tonometer.
- Secondary Outcome Measures
Name Time Method